Assignee
CYTLIMIC INC
JP8 patents
Top patents by PatentIndex Score
US10842848B2Nov 24, 2020
Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
CYTLIMIC INC2 citations69
US11304997B2Apr 19, 2022
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
CYTLIMIC INC0 citations60
US11491204B2Nov 8, 2022
Composition comprising poly I:C and LAG-3-IGG fusion protein
CYTLIMIC INC0 citations59
US11291718B2Apr 5, 2022
Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
CYTLIMIC INC0 citations59
US10875900B2Dec 29, 2020
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
CYTLIMIC INC0 citations50
US10590179B2Mar 17, 2020
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
CYTLIMIC INC0 citations50
US10537626B2Jan 21, 2020
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
CYTLIMIC INC0 citations50
US10526388B2Jan 7, 2020
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
CYTLIMIC INC0 citations50